STIM1-dependent store-operated Ca 2+ entry is required for pathological cardiac hypertrophy

Xiang Luo, Berdymammet Hojayev, Nan Jiang, Zhao Wang, Samvit Tandan, Andrey Rakalin, Beverly A Rothermel, Thomas G. Gillette, Joseph A Hill

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Alterations in intracellular Ca 2+ homeostasis are an important trigger of pathological cardiac remodeling; however, mechanisms governing context-dependent changes in Ca 2+ influx are poorly understood. Store-operated Ca 2+ entry (SOCE) is a major mechanism regulating Ca 2+ trafficking in numerous cell types, yet its prevalence in adult heart and possible role in physiology and disease are each unknown. The Ca 2+-binding protein, stromal interaction molecule 1 (STIM1), is a Ca 2+ sensor in the sarcoplasmic reticulum (SR), capable of triggering SOCE by interacting with plasma membrane Ca 2+ channels. We report that SOCE is abundant and robust in neonatal cardiomyocytes; however, SOCE is absent from adult cardiomyocytes. Levels of STIM1 transcript and protein correlate with the amplitude of SOCE, and manipulation of STIM1 protein levels (via shRNA) or activity (via expression of constitutively active or dominant-negative mutants) reveals a critical role for STIM1 in activating SOCE in cardiac myocytes. In neonatal hearts a recently identified STIM1 splice variant (STIM1L) is predominant but diminishes with maturation, only to reemerge with agonist- or afterload-induced cardiac stress. To test for pathophysiological relevance, we evaluated both in vitro and in vivo models of cardiac hypertrophy, finding that STIM1 expression is re-activated by pathological stress to trigger significant SOCE-dependent Ca 2+ influx. STIM1 amplifies agonist-induced hypertrophy via activation of the calcineurin-NFAT pathway. Importantly, inhibition of STIM1 suppresses agonist-triggered hypertrophy, pointing to a requirement for SOCE in this remodeling response. Stress-triggered STIM1 re-expression, and consequent SOCE activation, are critical elements in the upstream, Ca 2+-dependent control of pathological cardiac hypertrophy.

Original languageEnglish (US)
Pages (from-to)136-147
Number of pages12
JournalJournal of Molecular and Cellular Cardiology
Volume52
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Cardiomegaly
Cardiac Myocytes
Hypertrophy
Stromal Interaction Molecule 1
Calcineurin
Sarcoplasmic Reticulum
Small Interfering RNA
Proteins
Homeostasis
Cell Membrane

Keywords

  • Calcineurin
  • Calcium
  • Heart failure
  • Hypertrophy
  • Remodeling

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

STIM1-dependent store-operated Ca 2+ entry is required for pathological cardiac hypertrophy. / Luo, Xiang; Hojayev, Berdymammet; Jiang, Nan; Wang, Zhao; Tandan, Samvit; Rakalin, Andrey; Rothermel, Beverly A; Gillette, Thomas G.; Hill, Joseph A.

In: Journal of Molecular and Cellular Cardiology, Vol. 52, No. 1, 01.2012, p. 136-147.

Research output: Contribution to journalArticle

Luo, Xiang ; Hojayev, Berdymammet ; Jiang, Nan ; Wang, Zhao ; Tandan, Samvit ; Rakalin, Andrey ; Rothermel, Beverly A ; Gillette, Thomas G. ; Hill, Joseph A. / STIM1-dependent store-operated Ca 2+ entry is required for pathological cardiac hypertrophy. In: Journal of Molecular and Cellular Cardiology. 2012 ; Vol. 52, No. 1. pp. 136-147.
@article{daf462b99aad4ccebcf13011c063b1fe,
title = "STIM1-dependent store-operated Ca 2+ entry is required for pathological cardiac hypertrophy",
abstract = "Alterations in intracellular Ca 2+ homeostasis are an important trigger of pathological cardiac remodeling; however, mechanisms governing context-dependent changes in Ca 2+ influx are poorly understood. Store-operated Ca 2+ entry (SOCE) is a major mechanism regulating Ca 2+ trafficking in numerous cell types, yet its prevalence in adult heart and possible role in physiology and disease are each unknown. The Ca 2+-binding protein, stromal interaction molecule 1 (STIM1), is a Ca 2+ sensor in the sarcoplasmic reticulum (SR), capable of triggering SOCE by interacting with plasma membrane Ca 2+ channels. We report that SOCE is abundant and robust in neonatal cardiomyocytes; however, SOCE is absent from adult cardiomyocytes. Levels of STIM1 transcript and protein correlate with the amplitude of SOCE, and manipulation of STIM1 protein levels (via shRNA) or activity (via expression of constitutively active or dominant-negative mutants) reveals a critical role for STIM1 in activating SOCE in cardiac myocytes. In neonatal hearts a recently identified STIM1 splice variant (STIM1L) is predominant but diminishes with maturation, only to reemerge with agonist- or afterload-induced cardiac stress. To test for pathophysiological relevance, we evaluated both in vitro and in vivo models of cardiac hypertrophy, finding that STIM1 expression is re-activated by pathological stress to trigger significant SOCE-dependent Ca 2+ influx. STIM1 amplifies agonist-induced hypertrophy via activation of the calcineurin-NFAT pathway. Importantly, inhibition of STIM1 suppresses agonist-triggered hypertrophy, pointing to a requirement for SOCE in this remodeling response. Stress-triggered STIM1 re-expression, and consequent SOCE activation, are critical elements in the upstream, Ca 2+-dependent control of pathological cardiac hypertrophy.",
keywords = "Calcineurin, Calcium, Heart failure, Hypertrophy, Remodeling",
author = "Xiang Luo and Berdymammet Hojayev and Nan Jiang and Zhao Wang and Samvit Tandan and Andrey Rakalin and Rothermel, {Beverly A} and Gillette, {Thomas G.} and Hill, {Joseph A}",
year = "2012",
month = "1",
doi = "10.1016/j.yjmcc.2011.11.003",
language = "English (US)",
volume = "52",
pages = "136--147",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - STIM1-dependent store-operated Ca 2+ entry is required for pathological cardiac hypertrophy

AU - Luo, Xiang

AU - Hojayev, Berdymammet

AU - Jiang, Nan

AU - Wang, Zhao

AU - Tandan, Samvit

AU - Rakalin, Andrey

AU - Rothermel, Beverly A

AU - Gillette, Thomas G.

AU - Hill, Joseph A

PY - 2012/1

Y1 - 2012/1

N2 - Alterations in intracellular Ca 2+ homeostasis are an important trigger of pathological cardiac remodeling; however, mechanisms governing context-dependent changes in Ca 2+ influx are poorly understood. Store-operated Ca 2+ entry (SOCE) is a major mechanism regulating Ca 2+ trafficking in numerous cell types, yet its prevalence in adult heart and possible role in physiology and disease are each unknown. The Ca 2+-binding protein, stromal interaction molecule 1 (STIM1), is a Ca 2+ sensor in the sarcoplasmic reticulum (SR), capable of triggering SOCE by interacting with plasma membrane Ca 2+ channels. We report that SOCE is abundant and robust in neonatal cardiomyocytes; however, SOCE is absent from adult cardiomyocytes. Levels of STIM1 transcript and protein correlate with the amplitude of SOCE, and manipulation of STIM1 protein levels (via shRNA) or activity (via expression of constitutively active or dominant-negative mutants) reveals a critical role for STIM1 in activating SOCE in cardiac myocytes. In neonatal hearts a recently identified STIM1 splice variant (STIM1L) is predominant but diminishes with maturation, only to reemerge with agonist- or afterload-induced cardiac stress. To test for pathophysiological relevance, we evaluated both in vitro and in vivo models of cardiac hypertrophy, finding that STIM1 expression is re-activated by pathological stress to trigger significant SOCE-dependent Ca 2+ influx. STIM1 amplifies agonist-induced hypertrophy via activation of the calcineurin-NFAT pathway. Importantly, inhibition of STIM1 suppresses agonist-triggered hypertrophy, pointing to a requirement for SOCE in this remodeling response. Stress-triggered STIM1 re-expression, and consequent SOCE activation, are critical elements in the upstream, Ca 2+-dependent control of pathological cardiac hypertrophy.

AB - Alterations in intracellular Ca 2+ homeostasis are an important trigger of pathological cardiac remodeling; however, mechanisms governing context-dependent changes in Ca 2+ influx are poorly understood. Store-operated Ca 2+ entry (SOCE) is a major mechanism regulating Ca 2+ trafficking in numerous cell types, yet its prevalence in adult heart and possible role in physiology and disease are each unknown. The Ca 2+-binding protein, stromal interaction molecule 1 (STIM1), is a Ca 2+ sensor in the sarcoplasmic reticulum (SR), capable of triggering SOCE by interacting with plasma membrane Ca 2+ channels. We report that SOCE is abundant and robust in neonatal cardiomyocytes; however, SOCE is absent from adult cardiomyocytes. Levels of STIM1 transcript and protein correlate with the amplitude of SOCE, and manipulation of STIM1 protein levels (via shRNA) or activity (via expression of constitutively active or dominant-negative mutants) reveals a critical role for STIM1 in activating SOCE in cardiac myocytes. In neonatal hearts a recently identified STIM1 splice variant (STIM1L) is predominant but diminishes with maturation, only to reemerge with agonist- or afterload-induced cardiac stress. To test for pathophysiological relevance, we evaluated both in vitro and in vivo models of cardiac hypertrophy, finding that STIM1 expression is re-activated by pathological stress to trigger significant SOCE-dependent Ca 2+ influx. STIM1 amplifies agonist-induced hypertrophy via activation of the calcineurin-NFAT pathway. Importantly, inhibition of STIM1 suppresses agonist-triggered hypertrophy, pointing to a requirement for SOCE in this remodeling response. Stress-triggered STIM1 re-expression, and consequent SOCE activation, are critical elements in the upstream, Ca 2+-dependent control of pathological cardiac hypertrophy.

KW - Calcineurin

KW - Calcium

KW - Heart failure

KW - Hypertrophy

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=84155194910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155194910&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2011.11.003

DO - 10.1016/j.yjmcc.2011.11.003

M3 - Article

VL - 52

SP - 136

EP - 147

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 1

ER -